Cantitate/Preț
Produs

Changing Therapies in Type 2 Diabetes

Editat de R. D. G. Leslie, Paolo Pozzilli
en Limba Engleză Paperback – 25 apr 2002
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
Citește tot Restrânge

Preț: 32739 lei

Preț vechi: 37723 lei
-13% Nou

Puncte Express: 491

Preț estimativ în valută:
6266 6508$ 5204£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781841841113
ISBN-10: 1841841110
Pagini: 120
Dimensiuni: 140 x 210 x 8 mm
Greutate: 0.26 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:United Kingdom

Public țintă

Professional, Professional Practice & Development, and Professional Reference

Cuprins

The heterogeneity of type 2 diabetes. Preventing cardiovascular disease in diabetes. Insulin by mouth (buccalor inhaled). Long-acting insulin analogue. Potential of glitazones in diabetes. Clinical value of glitazones.

Descriere

The Seventh International Barts Symposium was held on April 20, 2001, in London. This text summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. World-renowned experts provide incisive commentary on their respective specialties, addressing new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the use of glitazones. Changing Therapies for Type 2 Diabetes is ideal for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.